Related Experiment Video
Updated: Aug 5, 2026

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
Starch based sulfobetaine zwitterionic coatings for anticoagulation
Ming Zeng1, Xianzhu You2, Xiangrong Dai2
1College of Life and Environmental Science, Wenzhou University. Wenzhou 325035, China.
A new, eco-friendly coating for medical devices prevents blood clots and infections. This starch-based zwitterionic material offers robust, long-lasting antifouling properties without toxic catalysts, enhancing device safety.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Surface Engineering
Background:
- Blood-contacting medical devices face challenges with thrombosis and bacterial infections.
- Traditional zwitterionic polymers for antifouling require complex synthesis and toxic catalysts.
- Developing safe, effective, and scalable antifouling coatings is crucial for biomedical applications.
Purpose of the Study:
- To develop a metal-catalyst-free strategy for fabricating a renewable starch-based sulfobetaine zwitterionic coating (OSt-SBSi).
- To achieve stable immobilization of the coating via covalent anchoring, preventing delamination.
- To evaluate the biofouling resistance and hemocompatibility of the novel coating.
Main Methods:
- Incorporation of zwitterionic antifouling and hydrolyzable silane groups onto a polymer backbone.
- Metal-catalyst-free synthesis of the OSt-SBSi coating.
- Covalent immobilization onto substrates using siloxane-based anchoring.
- Assessment of protein, cell, platelet, and bacterial adhesion.
- Evaluation of hemocompatibility and thrombus formation in an ex vivo blood circulation model.
Main Results:
- The OSt-SBSi coating demonstrated broad-spectrum resistance to biofouling, significantly reducing adhesion of proteins, cells, platelets, and bacteria.
- Stable, multi-site covalent anchoring prevented coating delamination.
- The coating exhibited excellent hemocompatibility, preventing thrombus formation in a dynamic ex vivo model.
- The OSt-SBSi coating maintained its structural integrity and anticoagulant activity after 7 days of immersion.
Conclusions:
- The developed scalable, eco-friendly, and metal-catalyst-free strategy yields a robust zwitterionic coating with excellent antifouling and hemocompatible properties.
- The OSt-SBSi coating effectively prevents biofouling and thrombosis, showing promise for next-generation blood-contacting biomedical devices.
- This approach overcomes limitations of traditional methods, offering a sustainable alternative for medical device coatings.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

